Criteria for Causality: Bradford Hill Criteria - II
Pharmacovigilance
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Strategies for Assessing and Addressing Confounding
Causality in Epidemiology
Vaccinations
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 23, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Neal A Halsey1, Kathryn M Edwards, Cornelia L Dekker
1Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. tproveau@jhsph.edu
A new algorithm standardizes the assessment of adverse events following immunizations (AEFI), improving data interpretation and causality determination for healthcare providers and scientists. This structured approach enhances transparency and aids in understanding vaccine safety.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: